The following data is part of a premarket notification filed by Alcresta Therapeutics, Inc. with the FDA for Relizorb.
| Device ID | K161247 |
| 510k Number | K161247 |
| Device Name: | Relizorb |
| Classification | Enzyme Packed Cartridge |
| Applicant | Alcresta Therapeutics, Inc. One Newton Executive Park, Suite 102 Newton, MA 02462 |
| Contact | Robert Gallotto |
| Correspondent | Nandini Murthy Alcresta Therapeutics, Inc. One Newton Executive Park, Suite 102 Newton, MA 02462 |
| Product Code | PLQ |
| CFR Regulation Number | 876.5985 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2016-05-03 |
| Decision Date | 2016-06-30 |
| Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RELIZORB 86690981 5087672 Live/Registered |
ALCRESTA THERAPEUTICS, INC. 2015-07-13 |